Course
NURS-6521N Advanced Pharmacology
Test
Week 6 -Quiz
Started
7/7/19
Submitted
7/7/19
Status
Completed
Attempt
Score
30 out of 30 points
Time Elapsed
47 minutes out of 1 hour and 15 minutes
Instructions
Please answer each question below and click
Submit
when you have completed
the Quiz.
Results
Displayed
Feedback
Question 1
1 out of 1 points
A nurse is caring for a 61-year-old man who has had a severe attack of gout while in the hospital for food
poisoning. The nurse administers colchicine intravenously in order to
Response
Feedback:
The patient is given colchicine intravenously to avoid aggravating his gastrointestinal
tract. Giving the drug intravenously may ensure quick distribution of the drug, but
considering the patient's food poisoning, the main objective would be to avoid aggravating
the gastrointestinal tract and symptoms that the patient already has. Giving the drug
intravenously does not prevent infection, bleeding, or depressed bone marrow function.
Question 2
1 out of 1 points
A 32-year-old female patient is taking tizanidine (Zanaflex) for spasticity related to her multiple sclerosis.
The nurse will inform the patient and her husband that the adverse effect that poses the greatest safety risk
to the patient is
Response
Feedback:
Tizanidine (Zanaflex) has been associated with hypotension, which could be a safety risk,
especially if the patient is also taking an antihypertensive drug. Constipation, dry mouth,
and fatigue are common adverse effects that do not pose a safety risk.
Question 3
1 out of 1 points
A nurse is instructing a patient in the administration of regular insulin by the subcutaneous route. Which of
the following strategies would the nurse suggest if the goal is to promote absorption of the regular insulin?
Response
Feedback:
To promote the absorption of regular insulin, one anatomic area should be selected for
subcutaneous injections. Serial locations within that anatomic area are then chosen to
rotate the exact injection site. Injection sites should not be rotated by using different
anatomic areas each day, because this would substantially change the absorption of the
insulin and the patient's blood glucose levels. Using one injection site regularly may lead
to lipodystrophy. Regular insulin is administered about 30 to 60 minutes before eating a
meal, not after.
Question 4
1 out of 1 points
A female patient with a diagnosis of type 1 diabetes mellitus has been experiencing increasing neuropathic
pain in recent months, a symptom that has not responded appreciably to conventional analgesics. The
patient's care provider has begun treatment with gabapentin (Neurontin). How is the addition of this drug

likely to influence the management of the patient's existing drug regimen?


You've reached the end of your free preview.
Want to read all 7 pages?
- Fall '13
- Nursing, Blood sugar, Allopurinol, Dantrolene , Nurs 6521 (T., 2018)